期刊文献+

人淋巴细胞犬尿氨酸酶活性的测定 被引量:1

Determination of Activity of Human Lymphocyte Kynureninase
下载PDF
导出
摘要 目的 建立人淋巴细胞犬尿氨酸酶活性的高效液相色谱检测法。方法 以人淋巴细胞总蛋白作为酶的来源,以3-羟基犬尿氨酸为底物,5’磷酸吡哆醛为辅酶,进行酶促反应,产物经ODS色谱柱分离后用荧光检测器定量检测,从单位时间内产物的增加量来计算犬尿氨酸酶的催化活性。结果 该方法检测产物的线性范围是2~400nmol/L。方法的重复性好,日内变异系数(CV)≤3.0%,日间CV≤3.2%。结论 该方法适用于测定各种生物组织样本中犬尿氨酸酶的活性。 Objective To develop an efficient method for the determination of activity of human lymphocyte kynureninase by high performance liquid chromatography. Methods Protein containing kynureninase was extracted from lymphocytes. The reaction was made with 3-hydroxyanthranilic acid as suhstrate and pyridoxal-5'-phosphate as coenzyme. The product was determined by high performance liquid chromatography and fluorescence detection. Results Standard curve of 3-hydroxyanthranilic acid was highly linear over the range from 2 to 400 nmol/L. The intra-day coefficient of variation(CV) was less than 3.0% and the inter-day CV was less than 3.2%. Conclusion The developed assay is efficient and can he used to determine the activity of kynureninase from kinds of tissues.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第11期1239-1241,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30270545)资助项目
关键词 犬尿氨酸酶 淋巴细胞 活性 高效液相色谱法 kynureninase lymphocyte activity high performance liquid chromatography
  • 引文网络
  • 相关文献

参考文献6

  • 1Ubbink JB,Vermaak WJ,Bissbort SH.High-performance liquid chromatographic assay of human lymphocyte kynureninase activity levels[J].J Chromatogr,1991,566(2):369-375.
  • 2Schwarcz R.The kynurenine pathway of tryptophan degradation as adrug target[J].Curr Opin Pharmacol,2004,4(1):12 -17.
  • 3Stone TW.Kynurenines in the CNS:from endogenous obscurity to therapeutic importance[J].Prog Neurobiol,2001,64 (2):185 -218.
  • 4Kapoor V,Kapoor R,Chalmers J.Kynurenic acid,an endogenous glutamate antagonist,in SHR and WKY rats:possible role in central blood pressure regulation[J].Clin Exp Pharmacol Physiol,1994,21(11):891 -896.
  • 5Moroni F.Tryptophan metabolism and brain function:focus on kynurenine and other indole metabolites[J].Eur J Phannacol,1999,375(1 -3):87 -100.
  • 6Schwarcz R,Pellicciari R.Manipulation of brain kynurenines:glial targets,neuronal effects,and clinical opportunities[J].J Pharmacol Exp Ther,2002,303(1):1 -10.

同被引文献2

引证文献1

相关主题

;
使用帮助 返回顶部